Nutra Pharma Corp. (NPHC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0002 (-66.67%)
May 7, 2025, 4:00 PM EDT
Nutra Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2012 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2012 - 2016 |
| Cash & Equivalents | - | 0.09 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | - | 0.09 | - | - | - | - | Upgrade
|
| Accounts Receivable | 0.02 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Other Receivables | 0 | 0.01 | 0 | - | - | 0.14 | Upgrade
|
| Receivables | 0.3 | 0.33 | 0.04 | 0.03 | 0.02 | 0.28 | Upgrade
|
| Inventory | 0.09 | 0.03 | 0.01 | 0.01 | 0.04 | 0.02 | Upgrade
|
| Prepaid Expenses | 0.07 | 0.07 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Other Current Assets | - | 0.02 | - | 0.01 | 0.05 | 0.04 | Upgrade
|
| Total Current Assets | 0.46 | 0.53 | 0.06 | 0.06 | 0.12 | 0.36 | Upgrade
|
| Property, Plant & Equipment | 0.13 | 0.14 | 0.16 | 0.21 | 0.01 | 0.02 | Upgrade
|
| Other Long-Term Assets | 0.1 | 0.11 | 0.09 | 0.07 | 0.02 | 0.02 | Upgrade
|
| Total Assets | 0.69 | 0.78 | 0.3 | 0.34 | 0.14 | 0.39 | Upgrade
|
| Accounts Payable | 0.71 | 0.67 | 0.6 | 0.58 | 0.48 | 0.39 | Upgrade
|
| Accrued Expenses | 2.28 | 2.05 | 2.39 | 2.02 | 2.02 | 1.91 | Upgrade
|
| Short-Term Debt | 2.03 | 3.28 | 2.26 | 6.09 | 2.11 | 3.47 | Upgrade
|
| Current Portion of Long-Term Debt | 5.89 | 4.52 | 2.59 | 1.39 | 1.42 | - | Upgrade
|
| Current Portion of Leases | 0.02 | 0.08 | 0.08 | 0.07 | - | - | Upgrade
|
| Current Unearned Revenue | 0.11 | - | - | - | - | 0.02 | Upgrade
|
| Other Current Liabilities | 5.1 | 10.54 | 3.57 | 0.84 | 0 | 0.01 | Upgrade
|
| Total Current Liabilities | 16.15 | 21.14 | 11.48 | 10.99 | 6.03 | 5.8 | Upgrade
|
| Long-Term Debt | 0.15 | 0.52 | 0.25 | 0.91 | 0.05 | - | Upgrade
|
| Long-Term Leases | - | - | 0.06 | 0.14 | - | - | Upgrade
|
| Total Liabilities | 16.3 | 21.66 | 11.8 | 12.04 | 6.08 | 5.8 | Upgrade
|
| Common Stock | 7.6 | 7.33 | 6.96 | 5.88 | 4.05 | 2.03 | Upgrade
|
| Additional Paid-In Capital | 53.57 | 53.51 | 50.18 | 50.28 | 51.29 | 49.94 | Upgrade
|
| Retained Earnings | -76.78 | -81.73 | -68.63 | -67.86 | -61.27 | -57.39 | Upgrade
|
| Total Common Equity | -15.62 | -20.89 | -11.5 | -11.7 | -5.94 | -5.41 | Upgrade
|
| Shareholders' Equity | -15.61 | -20.88 | -11.49 | -11.7 | -5.94 | -5.41 | Upgrade
|
| Total Liabilities & Equity | 0.69 | 0.78 | 0.3 | 0.34 | 0.14 | 0.39 | Upgrade
|
| Total Debt | 8.1 | 8.4 | 5.24 | 8.6 | 3.58 | 3.47 | Upgrade
|
| Net Cash (Debt) | -8.1 | -8.3 | -5.24 | -8.6 | -3.58 | -3.47 | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 7,597 | 7,364 | 7,268 | 7,260 | 6,855 | 2,032 | Upgrade
|
| Total Common Shares Outstanding | 7,597 | 7,331 | 6,955 | 5,877 | 4,047 | 2,032 | Upgrade
|
| Working Capital | -15.69 | -20.61 | -11.43 | -10.93 | -5.91 | -5.44 | Upgrade
|
| Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Tangible Book Value | -15.62 | -20.89 | -11.5 | -11.7 | -5.94 | -5.41 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Machinery | 0.25 | 0.19 | 0.15 | 0.14 | 0.14 | 0.14 | Upgrade
|
| Leasehold Improvements | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.